Skip to main navigation
Skip to search
Skip to main content
Home
Profiles
Research Units
Research Output
Prizes
Activities
Search by expertise, name or affiliation
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Scientific Meeting
Eadie, L.
(Participant)
Acute Lymphoblastic Leukamia (ALL) Research Group
Activity
:
Other
Description
Tavakoli PS, Eadie LN, Heatley SL, White DL.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Oral Presentation
Christchurch, New Zealand
Period
13 Jun 2019
→
15 Jun 2019